VP 002-Vision Pharma

N/A

Report date: 2022/02/07 17:15:18
NME

Base Information

Drug NameVP 002-Vision Pharma
Drug Alias NameN/A
ClassificationSmall molecules > Synthetic peptide > Peptide drug conjugate (PDC)
Mechanisms of ActionRNA interference
TargetsUpdating
Therapy Area/IndicationsOptic Atrophy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLions Eye Institute
China Registration ClassN/A

Develop Information

Active CompaniesLions Eye Institute
Inactive CompaniesN/A
Active IndicationsOptic Atrophy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A